Compound 300
Identifiers
- Canonical SMILES:
C[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12
- IUPAC name:
1-(4-benzoyl-3-methylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione
- InChi:
InChI=1S/C22H20FN3O3/c1-14-13-25(10-11-26(14)21(28)15-6-3-2-4-7-15)22(29)20(27)16-12-24-18-9-5-8-17(23)19(16)18/h2-9,12,14,24H,10-11,13H2,1H3/t14-/m0/s1
- InChiKey:
PNJPCIYMKXINDN-AWEZNQCLSA-N
External links
168318247 |
442121 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 8.59 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 393.15 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 2.72 | |||
TPSA | 73.48 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6892 | Talmapimod | DB05412 | |
0.6222 | LY-517717 | DB05713 | |
0.6131 | Pruvanserin | DB13094 | |
0.6000 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.5969 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5923 | Indoramin | DB08950 | |
0.5646 | Macimorelin | DB13074 | |
0.5608 | LTX-315 | DB12748 | |
0.5608 | Gramicidin D | DB00027 | |
0.5533 | TC-6987 | DB14854 | |
0.5500 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
0.5460 | Rucaparib | DB12332 | |
0.5440 | N-acetylserotonin | DB04275 | |
0.5431 | Indoleacetamide | DB08652 | |
0.5430 | Indibulin | DB06169 |